HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B M Buddle Selected Research

Bovine Tuberculosis

5/2016The effectiveness of parallel gamma-interferon testing in New Zealand's bovine tuberculosis eradication programme.
11/2011Development and evaluation of an enzyme-linked immunosorbent assay for use in the detection of bovine tuberculosis in cattle.
7/2011Newly attenuated Mycobacterium bovis mutants as vaccines against bovine tuberculosis, particularly for possums.
9/2009Identification of novel Mycobacterium bovis antigens by dissection of crude protein fractions.
2/2006Progress in the development of tuberculosis vaccines for cattle and wildlife.
6/2005Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
11/2003Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle.
4/2003A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
1/2003Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis.
9/2002New generation vaccines and delivery systems for control of bovine tuberculosis in cattle and wildlife.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B M Buddle Research Topics

Disease

18Bovine Tuberculosis
05/2016 - 05/2000
17Tuberculosis (Tuberculoses)
11/2013 - 06/2000
12Infections
05/2016 - 04/2000
3Hypersensitivity (Allergy)
01/2005 - 10/2000
1Human Influenza (Influenza)
04/2010
1Influenza in Birds (Avian Flu)
04/2010
1Communicable Diseases (Infectious Diseases)
06/2009
1Mastitis
06/2009
1Bovine Mastitis
06/2009
1Inflammation (Inflammations)
04/2005
1Conjunctivitis
02/2004
1Cutaneous Tuberculosis (Scrofuloderma)
11/2003
1Paratuberculosis (Johne's Disease)
11/2003

Drug/Important Bio-Agent (IBA)

20VaccinesIBA
11/2013 - 07/2000
10Tuberculin (PPD)IBA
05/2016 - 05/2000
7AntigensIBA
09/2009 - 05/2000
6Interferon-gamma (Interferon, gamma)IBA
05/2016 - 05/2000
6Proteins (Proteins, Gene)FDA Link
06/2005 - 06/2000
4Tuberculosis VaccinesIBA
12/2002 - 04/2000
3BCG VaccineFDA Link
04/2003 - 01/2001
3Interleukin-2 (IL2)IBA
05/2002 - 05/2000
2Indicators and Reagents (Reagents)IBA
03/2006 - 12/2002
2A-Form DNA (A-DNA)IBA
04/2003 - 01/2003
1InterferonsIBA
01/2014
1Immunoglobulins (Immunoglobulin)IBA
01/2014
1ImmunosorbentsIBA
11/2011
1EnzymesIBA
11/2011
1AntibodiesIBA
04/2010
1Cell ExtractsIBA
09/2009
1Anti-Bacterial Agents (Antibiotics)IBA
06/2009
1LipidsIBA
03/2006
1CPG-oligonucleotideIBA
06/2005
1Immunologic Factors (Immunomodulators)IBA
06/2005
1OligodeoxyribonucleotidesIBA
06/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2004
1Peptides (Polypeptides)IBA
11/2003
1Recombinant ProteinsIBA
11/2003
1DNA VaccinesIBA
01/2003
1DNA (Deoxyribonucleic Acid)IBA
01/2003
1Subunit VaccinesIBA
12/2002
1PhosphoenolpyruvateIBA
10/2002
1SolutionsIBA
05/2002
1AerosolsIBA
07/2001
1CytokinesIBA
05/2000
1AG 85IBA
05/2000
1Biological ProductsIBA
04/2000
1PoisonsIBA
04/2000

Therapy/Procedure

2Oral Administration
01/2014 - 01/2005
1Therapeutics
06/2009